A Study of the Value of p53, HER2, and Bcl-2 in the Prediction of Response to Doxorubicin and Paclitaxel as Single Agents in Metastatic Breast Cancer: A Companion Study to EORTC 10923
Titel:
A Study of the Value of p53, HER2, and Bcl-2 in the Prediction of Response to Doxorubicin and Paclitaxel as Single Agents in Metastatic Breast Cancer: A Companion Study to EORTC 10923
Auteur:
Hamilton, A. Larsimont, D. Paridaens, R. Drijkoningen, M. van de Vijver, M. Bruning, P. Hanby, A. Houston, S. Treilleux, I. Guastalla, J.P. Van Vreckem, A. Sylvester, R. Piccart, M.